The human papillomavirus (HPV) can cause cancer and many countries run national vaccination programs to minimize the risk. Studies involving researchers at German Cancer Research Center, Karolinska Institutet and Tampere ...
May 31, 2021
0
17
A study led by Hui-Yi Lin, Ph.D., Professor of Biostatistics, and a team of researchers at LSU Health New Orleans Schools of Public Health and Medicine has found that adequate levels of five antioxidants may reduce infection ...
Apr 12, 2021
0
10
(HealthDay)—Fifteen years of widespread vaccination of U.S. children with the human papillomavirus (HPV) vaccine is reaping big rewards: A more than 80% drop in new infections has been seen in women and girls under the ...
Mar 26, 2021
0
8
(HealthDay)—Human papillomavirus (HPV) infection in the oral cavity has been detected in infants and young children, according to a study published in the March issue of Emerging Infectious Diseases, a publication of the ...
Feb 11, 2021
0
5
According to 2018 data, one in five people in the United States probably carries a sexually transmitted infection, the U.S. Centers for Disease Control and Prevention says.
Jan 26, 2021
0
25
A research team at Dartmouth's and Dartmouth-Hitchcock's Norris Cotton Cancer Center has found that the same vaccination programs that target human papillomavirus (hrHPV) strains in the United States may not be as effective ...
Jun 4, 2020
0
0
Gardnerella bacteria in the cervicovaginal microbiome may serve as a biomarker to identify women infected with human papillomavirus (HPV) who are at risk for progression to precancer, according to a study published March ...
Mar 26, 2020
0
10
The human papillomavirus (HPV) is the main cause of several cancers, including cervical cancer, which kills almost 300,000 women around the world each year. Although vaccines offer a proven first line of defense against HPV ...
Mar 24, 2020
0
213
Viruses get a bad rap as potential cancer-causers, but at least one class of viruses that commonly live on human skin—so-called "low-risk" human papillomaviruses—appear to play an unwitting role in protecting us against ...
Oct 30, 2019
0
303
The Griffith University scientists used CRISPR-Cas9 to successfully target and treat cervical cancer tumours in vivo (via injection into live and tumour-bearing mice) using "stealth" nanoparticles.
Oct 10, 2019
0
617
